548 related articles for article (PubMed ID: 11935151)
1. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
[TBL] [Abstract][Full Text] [Related]
2. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
Liinamaa MJ; Savolainen MJ
Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
4. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Uchita M; Matsuzaki T; Takayama M; Shinmura K; Yamada M
Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602
[TBL] [Abstract][Full Text] [Related]
5. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
[TBL] [Abstract][Full Text] [Related]
6. [Effect of retinal coagulation status on oxidative metabolite and VEGF in 208 patients with proliferative diabetic retinopathy].
Augustin AJ; Keller A; Koch F; Jurklies B; Dick B
Klin Monbl Augenheilkd; 2001 Feb; 218(2):89-94. PubMed ID: 11258131
[TBL] [Abstract][Full Text] [Related]
7. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
8. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
9. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
10. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
Zhou H; Zhang H
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
Merlak M; Kovacević D; Balog T; Marotti T; Misljenović T; Mikulicić M; Dekaris I
Coll Antropol; 2008 Oct; 32 Suppl 2():39-43. PubMed ID: 19138004
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
[TBL] [Abstract][Full Text] [Related]
14. Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy.
Ishizaki E; Takai S; Ueki M; Maeno T; Maruichi M; Sugiyama T; Oku H; Ikeda T; Miyazaki M
Am J Ophthalmol; 2006 Jan; 141(1):129-134. PubMed ID: 16386986
[TBL] [Abstract][Full Text] [Related]
15. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
16. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.
Funatsu H; Yamashita H; Noma H; Mimura T; Sakata K; Hori S
Br J Ophthalmol; 2004 Aug; 88(8):1064-8. PubMed ID: 15258026
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.
Mathews MK; Merges C; McLeod DS; Lutty GA
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725
[TBL] [Abstract][Full Text] [Related]
20. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
